Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm

被引:38
|
作者
Nasrullah, Muazzam [1 ]
Wesolowski, Laura G. [1 ]
Meyer, William A., III [2 ]
Owen, S. Michele [1 ]
Masciotra, Silvina [1 ]
Vorwald, Craig [3 ]
Becker, William J. [4 ]
Branson, Bernard M. [1 ]
机构
[1] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis STD & TB Prevent, Atlanta, GA USA
[2] Quest Diagnost, Baltimore, MD USA
[3] Quest Diagnost, Collegeville, PA USA
[4] Quest Diagnost, Lenexa, KS USA
关键词
fourth-generation immunoassay; HIV testing algorithms; specificity; ANTIBODY-ASSAYS; UNITED-STATES; WESTERN-BLOT; P24; ANTIGEN; INFECTION; TRANSMISSION; RNA; SEROCONVERSION; IMMUNOASSAY; PLASMA;
D O I
10.1097/QAD.0b013e32835bc535
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: We evaluated the performance of the GS fourth-generation antigen/antibody assay and compared Centers for Disease Control and Prevention's (CDC's) proposed alternative algorithm [repeatedly reactive fourth-generation immunoassay followed by an HIV-1/HIV-2 differentiation immunoassay and, if needed, nucleic acid test (NAT)] with the current algorithm (repeatedly reactive third-generation immunoassay followed by HIV-1 western blot). Design: A convenience sample of the following four specimen sets was acquired: 10 014 from insurance applicants, 493 known western blot-positive, 20 known western blot-indeterminate specimens, and 230 specimens from 26 HIV-1 seroconverters. Methods: Specimens were tested with the GS third-generation and fourth-generation immunoassays, the Multispot HIV-1/HIV-2 differentiation immunoassay, NAT, and western blot. We applied the two algorithms using these results. Results: Among insurance specimens, 13 (0.13%) specimens were immunoassay repeatedly reactive: two were HIV-positive (repeatedly reactive by third-generation and fourth-generation immunoassays, and western blot and Multispot positive); two third-generation repeatedly reactive and nine fourth-generation repeatedly reactive specimens were false-positive. Third-generation and fourth-generation specificities were 99.98% [95% confidence interval (CI) 99.93-100%] and 99.91% (95% CI 99.84-99.96%), respectively. All HIV-1 western blot-positive specimens were repeatedly reactive by third-generation and fourth-generation immunoassays. By Multispot, 491 (99.6%) were HIV-1-positive and two (0.4%) were HIV-2-positive. Only eight (40%) western blot-indeterminate specimens were fourth-generation repeatedly reactive: six were Multispot and NAT-negative and two were Multispot HIV-1-positive but NAT-negative. The alternative algorithm correctly classified as positive 102 seroconverter specimens with the third-generation immunoassay and 130 with the fourth-generation immunoassay compared with 56 using the western blot with either immunoassay. Conclusion: The alternative testing algorithm improved early infection sensitivity and identified HIV-2 infections. Two potential false-positive algorithm results occurred with western blot-indeterminate specimens. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins AIDS 2013, 27:731-737
引用
收藏
页码:731 / 737
页数:7
相关论文
共 50 条
  • [1] HIV Screening: When Is a Fourth-Generation Assay Useful?
    Livingston, Stephanie
    Singh, Harmanjot
    Hoang, Chau
    Pearlman, Eugene
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [2] Fourth-Generation HIV Testing
    Rose, Michael R.
    Chida, Natasha M.
    Jones, Joyce L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (23): : 2297 - 2298
  • [3] Delayed HIV primary infection diagnosis with a fourth-generation HIV assay
    Delforge, ML
    Dollé, N
    Hermans, P
    Liesnard, C
    AIDS, 2002, 16 (01) : 128 - 130
  • [4] Performance evaluation of a new fourth-generation HIV combination antigen–antibody assay
    A. Mühlbacher
    H. Schennach
    J. van Helden
    T. Hebell
    G. Pantaleo
    P. Bürgisser
    C. Cellerai
    P. Permpikul
    M. I. Rodriguez
    A. Eiras
    F. Alborino
    P. Cunningham
    M. Axelsson
    S. Andersson
    O. Wetlitzky
    C. Kaiser
    P. Möller
    G. de Sousa
    Medical Microbiology and Immunology, 2013, 202 : 77 - 86
  • [5] Clinical Application Evaluation of a Fourth-Generation HIV Antigen Antibody Combination Screening Assay
    Han, Hui
    Huang, Yanhua
    Dong, Qian
    Huang, Yunxiu
    Lu, Jianqiang
    Wang, Weijia
    Chen, Kang
    CLINICAL LABORATORY, 2019, 65 (10) : 1853 - 1858
  • [6] Acute HIV Infection and Implications of Fourth-Generation HIV Screening in Emergency Departments
    Haukoos, Jason S.
    Lyons, Michael S.
    White, Douglas A. E.
    Hsieh, Yu-Hsiang
    Rothman, Richard E.
    ANNALS OF EMERGENCY MEDICINE, 2014, 64 (05) : 547 - 551
  • [7] Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay
    Muehlbacher, A.
    Schennach, H.
    van Helden, J.
    Hebell, T.
    Pantaleo, G.
    Buergisser, P.
    Cellerai, C.
    Permpikul, P.
    Rodriguez, M. I.
    Eiras, A.
    Alborino, F.
    Cunningham, P.
    Axelsson, M.
    Andersson, S.
    Wetlitzky, O.
    Kaiser, C.
    Moeller, P.
    de Sousa, G.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (01) : 77 - 86
  • [8] Is Western blot alone sufficient to confirm a reactive result of a fourth-generation HIV screening assay?
    Dobec, Marinko
    Naegeli, Adrian
    Furrer, Kurt
    Kaeppeli, Franz
    SWISS MEDICAL WEEKLY, 2006, 136 (41-42) : 672 - 673
  • [9] Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay - evaluation of a new HIV assay
    Wang, Tingting
    Li, Dongdong
    Yan, Kening
    Yuan, Yu
    Yang, Tingfu
    Du, Xiaoqing
    Yan, Xuedan
    Tao, Chuanmin
    Wang, Lanlan
    INTERNATIONAL JOURNAL OF STD & AIDS, 2014, 25 (04) : 267 - 272
  • [10] Fourth-Generation HIV Rapid Tests: Enhanced Sensitivity and Reduced Diagnostic Window for HIV-1 Primary Infection Screening
    Guiraud, Vincent
    Naizet, Angele
    Khan, Habiba
    Benhafoun, Ghizlane
    Hernandez, Pierre
    Piccin, Luigi
    Pichon, Agnes
    Leng, Ay Ling
    Yousfi, Lena
    Gautheret-Dejean, Agnes
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (11)